Clinical Trial Update: Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia

View source ↗

Summary

A completed AstraZeneca-sponsored trial evaluated the validity of the Spanish version of the Subjective Well-being Under Neuroleptics Scale (SWN-K) in patients …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia
• Schizophreniform Disorder

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia, Schizoaffective Disorder | Status: COMPLETED